These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25287561)

  • 1. Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma.
    Cade TJ; Quinn MA; Rome RM; Polyakov A
    Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):453-6. PubMed ID: 25287561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between receptor status and results of treatment in endometrial carcinoma].
    Baĭnazarova AA; Iskakova ZhK
    Vopr Onkol; 2006; 52(6):654-8. PubMed ID: 17338243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial stromal sarcoma involving the urinary bladder: a study of 6 cases.
    Tian W; Latour M; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):982-9. PubMed ID: 24705317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 cases.
    Yoon A; Park JY; Park JY; Lee YY; Kim TJ; Choi CH; Bae DS; Kim BG; Lee JW; Nam JH
    Gynecol Oncol; 2014 Jan; 132(1):70-5. PubMed ID: 24184602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade endometrial stromal sarcoma: hormonal aspects.
    Chu MC; Mor G; Lim C; Zheng W; Parkash V; Schwartz PE
    Gynecol Oncol; 2003 Jul; 90(1):170-6. PubMed ID: 12821359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.
    Reich O; Regauer S; Urdl W; Lahousen M; Winter R
    Br J Cancer; 2000 Mar; 82(5):1030-4. PubMed ID: 10737385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
    Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
    Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study.
    Dahhan T; Fons G; Buist MR; Ten Kate FJ; van der Velden J
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):80-4. PubMed ID: 19269732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
    Lipponen P; Eskelinen M; Papinaho S; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
    Anticancer Res; 1992; 12(3):677-82. PubMed ID: 1622125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases.
    Bai H; Yang J; Cao D; Huang H; Xiang Y; Wu M; Cui Q; Chen J; Lang J; Shen K
    Gynecol Oncol; 2014 Mar; 132(3):654-60. PubMed ID: 24412112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.
    Stewart LE; Beck TL; Giannakopoulos NV; Rendi MH; Isacson C; Goff BA
    Gynecol Oncol; 2018 May; 149(2):297-300. PubMed ID: 29534832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase inhibitor therapy for endometrial stromal sarcoma - two-centre experience.
    Serkies K; Abacjew-Chmyłko A; Wieczorek-Rutkowska M; Pęksa R
    Ginekol Pol; 2018; 89(11):607-610. PubMed ID: 30508212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.
    Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S
    Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
    Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.
    Park JY; Baek MH; Park Y; Kim YT; Nam JH
    Virchows Arch; 2018 Jul; 473(1):61-69. PubMed ID: 29869299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.